Lung Cancer
From the Journals
Selpercatinib ‘poised to alter the landscape’ of RET+ cancers
From the Journals
Aspirin may accelerate cancer progression in older adults
From the Journals
Black/White gap gone: ‘The only cancer where this has happened’
News
Treatment for a tobacco-dependent adult
A tobacco user is ready to try quitting. Here’s what you can you offer him.
From the Journals
Incidence, prognosis of second lung cancers support long-term surveillance
A study using SEER data finds that overall survival of surgically resected second primary lung cancers occurring 4-10 years out is similar to that...
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
From the Journals
NSCLC success story: Mortality down, survival improved
In recent years, mortality rates have fallen and survival has improved for patients with non–small cell lung cancer.
Conference Coverage
Sintilimab scintillates in first-line nonsquamous NSCLC
Conference Coverage
Chemo-free management of mesothelioma on horizon
News from the FDA/CDC
FDA approves first liquid biopsy/NGS test for lung cancer